MA40021A - Processus de culture cellulaire destiné à produire une protéine - Google Patents

Processus de culture cellulaire destiné à produire une protéine

Info

Publication number
MA40021A
MA40021A MA040021A MA40021A MA40021A MA 40021 A MA40021 A MA 40021A MA 040021 A MA040021 A MA 040021A MA 40021 A MA40021 A MA 40021A MA 40021 A MA40021 A MA 40021A
Authority
MA
Morocco
Prior art keywords
cell culture
culture process
protein
producing
mammalian cell
Prior art date
Application number
MA040021A
Other languages
English (en)
Inventor
Sridhar Kottakota
Sorab Rustom Mody
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of MA40021A publication Critical patent/MA40021A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components

Abstract

L'invention concerne un processus de culture cellulaire de mammifère destiné à la production d'anticorps monoclonaux et de protéines hybrides. La cellule de mammifère est mise en culture dans des conditions de culture cellulaire appropriées permettant de maintenir de manière spécifique la température monophasique.
MA040021A 2014-06-03 2015-06-03 Processus de culture cellulaire destiné à produire une protéine MA40021A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1827MU2014 2014-06-03

Publications (1)

Publication Number Publication Date
MA40021A true MA40021A (fr) 2015-12-10

Family

ID=53476939

Family Applications (1)

Application Number Title Priority Date Filing Date
MA040021A MA40021A (fr) 2014-06-03 2015-06-03 Processus de culture cellulaire destiné à produire une protéine

Country Status (12)

Country Link
US (1) US20170107553A1 (fr)
EP (1) EP3152318A1 (fr)
JP (1) JP2017516484A (fr)
CN (1) CN106536746A (fr)
AU (1) AU2015270137A1 (fr)
BR (1) BR112016028538A2 (fr)
CA (1) CA2951025A1 (fr)
MA (1) MA40021A (fr)
MX (1) MX2016015971A (fr)
PH (1) PH12016502406A1 (fr)
RU (1) RU2016152693A (fr)
WO (1) WO2015186075A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR095196A1 (es) 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
TW202340452A (zh) 2015-08-04 2023-10-16 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法
KR101936049B1 (ko) * 2015-10-15 2019-01-08 (주)알테오젠 IgG Fc 도메인을 가지는 융합 단백질의 생산방법
WO2018073365A1 (fr) * 2016-10-19 2018-04-26 F. Hoffmann-La Roche Ag Procédé de production d'un immunoconjugué
TW201934570A (zh) * 2017-07-06 2019-09-01 美商雷傑納榮製藥公司 供製備糖蛋白之細胞培養方法
CN112852743B (zh) * 2021-01-25 2021-11-02 江苏荃信生物医药有限公司 用于生产乌司奴单抗的生物类似药的细胞株及生产方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705364A (en) * 1995-06-06 1998-01-06 Genentech, Inc. Mammalian cell culture process
US6673575B1 (en) * 1997-12-03 2004-01-06 Roche Diagnostics Gmbh Method for preparing polypeptides with appropriate glycosilation
US7294481B1 (en) 1999-01-05 2007-11-13 Immunex Corporation Method for producing recombinant proteins
US20040185534A1 (en) * 2000-10-02 2004-09-23 Knudsen Ida Molgaard Industrial-scale serum-free production of recombinant proteins in mammalian cells
PT2235197T (pt) * 2007-12-27 2017-10-11 Baxalta Inc Processos para cultura de células

Also Published As

Publication number Publication date
JP2017516484A (ja) 2017-06-22
BR112016028538A2 (pt) 2017-08-22
WO2015186075A1 (fr) 2015-12-10
EP3152318A1 (fr) 2017-04-12
AU2015270137A1 (en) 2016-12-22
PH12016502406A1 (en) 2017-02-27
RU2016152693A (ru) 2018-07-09
RU2016152693A3 (fr) 2018-11-06
US20170107553A1 (en) 2017-04-20
CA2951025A1 (fr) 2015-12-10
CN106536746A (zh) 2017-03-22
MX2016015971A (es) 2017-08-08

Similar Documents

Publication Publication Date Title
PH12016502406A1 (en) Cell culture process for producing a protein
MX2021008143A (es) Metodos para cosechar cultivos de celulas de mamifero.
NZ715246A (en) Improved process for production of monoclonal antibodies
BR112019025583A2 (pt) Anticorpos multiespecíficos geneticamente modificados e outras proteínas multiméricas com mutações assimétricas na região ch2-ch3
MA51794A (fr) Procédés d'isolation, de culture et de modification génétique de populations de cellules immunitaires pour thérapie adoptive
MX2020011334A (es) Cultivo celular metabolicamente optimizado.
SG10201809146QA (en) Recombinant host cell engineered to overexpress helper proteins
NZ630568A (en) Methods and means for the production of ch3 domain-comprising molecules
SG10201809152QA (en) Recombinant host cell for expressing proteins of interest
MX2018014043A (es) Composiciones de cultivo celular con antioxidantes y metodos para la produccion de polipeptidos.
EP3476933A4 (fr) Feuille de peau de culture tridimensionnelle, cuve de culture de cellules utilisée pour la production de celle-ci, et procédé de production de feuille de peau de culture tridimensionnelle
MX366112B (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
IL276910A (en) Fully fucose-free glycoforms of antibodies are produced in cell culture
EP3448884C0 (fr) Cellules de mammifères modifiées pour la production de protéines recombinantes
EP3162892A4 (fr) Procédé de culture de cellules adhérentes, récipient de culture et procédé de production de protéines
SG11201707858TA (en) Human serum albumin-containing culture medium for growth of neural stem cells
IL269197A (en) Control of fully apocosylated antibody glycoforms produced in cell culture
BR112016028512A8 (pt) método de cultivo de uma célula de mamífero e método de produção de uma proteína recombinante
EP3140392A4 (fr) Production de protéines hétéromultimères au moyen de cellules mammaliennes
EP3407729A4 (fr) Biomasse de matière contenant des protéines et procédés de production
BR112017009152A2 (pt) métodos de produção de proteínas de duas cadeias em bactérias
EA201992828A1 (ru) Способы культивирования клеток
MX2022003016A (es) Metodo de produccion con iones de cobre controlados.
HK1221977A1 (zh) 用於產生供生產重組蛋白的哺乳動物生產細胞的物品和方法
EP3150700A4 (fr) Milieu de culture et procédé de culture pour cellules adhérentes, composition cellulaire contenant des cellules souches et/ou des cellules différenciées issues de cellules souches, et procédé de production de ladite composition cellulaire